MILNE GEORGE M JR — SEC insider filings

SEC reporting owner CIK 1179552. 21 insider filings on record with FilingPulse; latest filed 2026-10-07.

Transaction summary — filings shown

Covers all 21 filings on record, filed 2021-03-02 to 2026-10-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Amylyx Pharmaceuticals, Inc. (AMLX)Director132 legs · 126,315 sh · $719,7853 legs · 65,000 sh · $1,946,97610
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)Director2—1 leg · 3,530 sh · $1,023,7305
Aurinia Pharmaceuticals Inc. (AUPH)Director63 legs · 30,000 sh · $297,384—5

Insider filings — MILNE GEORGE M JR

FiledFormIssuerReported transactionsSource
2026-10-074Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 30,000 @ $27.70EDGAR
2026-06-084Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 24,372 (derivative) @ $0EDGAR
2026-01-144Amylyx Pharmaceuticals, Inc. (AMLX)Gift (G): 17,780 @ $0EDGAR
2025-06-094Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2025-01-284Amylyx Pharmaceuticals, Inc. (AMLX)Gift (G): 27,910 @ $0EDGAR
2024-09-054Amylyx Pharmaceuticals, Inc. (AMLX)Purchase (P): 100,000 @ $2.20EDGAR
2024-06-074Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2024-01-294Amylyx Pharmaceuticals, Inc. (AMLX)Gift (G): 9,100 @ $0EDGAR
2024-01-184Amylyx Pharmaceuticals, Inc. (AMLX)Gift (G): 94,350 @ $0EDGAR
2023-06-124Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 16,985 (derivative) @ $0EDGAR
2023-05-234Aurinia Pharmaceuticals Inc. (AUPH)Option exercise (M): 8,733 · Option exercise (M): 8,733 (derivative) @ $0EDGAR
2023-03-204Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 33,084 @ $31.86 · Sale (S): 1,916 @ $32.45EDGAR
2023-03-064Aurinia Pharmaceuticals Inc. (AUPH)Purchase (P): 20,000 @ $8.91EDGAR
2022-06-104Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 19,000 (derivative) @ $0EDGAR
2022-05-204Aurinia Pharmaceuticals Inc. (AUPH)Grant/award (A): 8,733 (derivative) @ $0 · Grant/award (A): 14,612 (derivative) @ $0EDGAR
2022-03-084Aurinia Pharmaceuticals Inc. (AUPH)Purchase (P): 5,000 @ $10.82EDGAR
2022-01-104Amylyx Pharmaceuticals, Inc. (AMLX)Purchase (P): 26,315 @ $19 · Grant/award (A): 8,400 (derivative) @ $0EDGAR
2021-06-164Aurinia Pharmaceuticals Inc. (AUPH)Grant/award (A): 31,347 (derivative) @ $0EDGAR
2021-05-104CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)Grant/award (A): 355 @ $0 · Grant/award (A): 307 @ $0 · Grant/award (A): 1,151 (derivative) @ $0EDGAR
2021-03-094Aurinia Pharmaceuticals Inc. (AUPH)Purchase (P): 5,000 @ $13EDGAR
2021-03-024CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)Option exercise (M): 3,530 @ $52.29 · Sale (S): 3,530 @ $290.01 · Option exercise (M): 3,530 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-03-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1179552 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs